Sign In
Buy MNKD
$3.36
-0.0700 (-2.04%)
At Close: Jun 03, 2026
3 Penny Stocks With Triple-Digit Upside Potential
02:50pm, Tuesday, 31'st Mar 2020
Buckle up, we’re in for a bumpy ride. The number of new coronavirus (COVID-19) cases continues to surge, and as such, the market’s volatility has
United Therapeutics (UTHR) Down 8.7% Since Last Earnings Report: Can It Rebound?
03:30pm, Friday, 27'th Mar 2020
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jennifer Grancio Appointed to MannKind Board of Directors
01:00pm, Tuesday, 24'th Mar 2020
MannKind Corporation (MNKD) today announced that Jennifer Grancio has been appointed to its Board of Directors, effective March 23, 2020. Ms. Grancio will also serve as a member of the Audit Committe
United Therapeutics (NASDAQ:UTHR) and Tetralogic Pharmaceuticals (NASDAQ:TLOG) Head to Head Survey
06:06am, Sunday, 22'nd Mar 2020
United Therapeutics (NASDAQ:UTHR) and Tetralogic Pharmaceuticals (OTCMKTS:TLOG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of
MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic
01:00pm, Tuesday, 17'th Mar 2020
MannKind Corporation (MNKD), a company focused on the development and commercialization of inhaled therapeutic products, today announced that it is adjusting research and development resources that w
Reviewing GW Pharmaceuticals PLC- (NASDAQ:GWPH) and United Therapeutics (NASDAQ:UTHR)
05:32am, Saturday, 14'th Mar 2020
GW Pharmaceuticals PLC- (NASDAQ:GWPH) and United Therapeutics (NASDAQ:UTHR) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the stren
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Edited Transcript of MNKD earnings conference call or presentation 25-Feb-20 2:00pm GMT
08:31am, Saturday, 07'th Mar 2020
Q4 2019 MannKind Corp Earnings Call
MannKind shares are trading lower, reversing from pre-market strength. The company earlier reported Q4 results.
03:23pm, Tuesday, 25'th Feb 2020MannKind shares are trading higher after the company reported better-than-expected Q4 sales results.
01:36pm, Tuesday, 25'th Feb 2020The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
01:28pm, Tuesday, 25'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results
01:00pm, Tuesday, 25'th Feb 2020
2019 Total Revenue of $63.0 million ° 2019 Afrezza Net Revenue of $25.3 million; +46% vs. 2018° 2019 Collaborations and Services Revenue of $37.7 million; +257%.
